Mirae Asset Global Investments’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.6K | Buy |
1,048
+142
| +16% | +$1.85K | ﹤0.01% | 1446 |
|
|
2025
Q1 | $10.5K | Buy |
906
+3
| +0.3% | +$35 | ﹤0.01% | 1468 |
|
|
2024
Q4 | $15.4K | Sell |
903
-75
| -8% | -$1.28K | ﹤0.01% | 1457 |
|
|
2024
Q3 | $21.5K | Buy |
978
+174
| +22% | +$3.83K | ﹤0.01% | 1423 |
|
|
2024
Q2 | $19.7K | Sell |
804
-14,269
| -95% | -$349K | ﹤0.01% | 1380 |
|
|
2024
Q1 | $335K | Sell |
15,073
-2,496
| -14% | -$55.4K | ﹤0.01% | 2064 |
|
|
2023
Q4 | $554K | Sell |
17,569
-376
| -2% | -$11.9K | ﹤0.01% | 1911 |
|
|
2023
Q3 | $458K | Sell |
17,945
-1,126
| -6% | -$28.8K | ﹤0.01% | 1928 |
|
|
2023
Q2 | $536K | Buy |
19,071
+2,813
| +17% | +$79K | ﹤0.01% | 1916 |
|
|
2023
Q1 | $390K | Buy |
16,258
+6,039
| +59% | +$145K | ﹤0.01% | 2046 |
|
|
2022
Q4 | $173K | Buy |
10,219
+7
| +0.1% | +$119 | ﹤0.01% | 2334 |
|
|
2022
Q3 | $152K | Buy |
+10,212
| New | +$152K | ﹤0.01% | 2420 |
|